Hyperalgesia and NMDA Receptor Antagonist

NCT02087202 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2014-03-14

No results posted yet for this study

Summary

NMDA receptor is administered and postoperative remote hyperalgesia is investigated.

Conditions

Interventions

DRUG

Magnesium Sulfate

magnesium sulfate is added to the patients

DRUG

ketamine

ketamine is added to the patients.

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2014-07-31
Completion
2014-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02087202 on ClinicalTrials.gov